Bacterial Exacerbation of Chronic Bronchitis
📧 Sign up to get email alerts when something new happens for Bacterial Exacerbation of Chronic Bronchitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-05-01FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Northstar RxLLC)
FDA approved a supplemental application for Amoxicillin and clavulanate potassium (amoxicillin-clavulanate) from Northstar RxLLC, authorizin…
-
FDA approval · 2022-01-31FDA Approved: CLARITHROMYCIN — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' generic clarithromycin under Original Application ANDA210459. This expands access to clarithromycin as…
-
FDA approval · 2016-07-26FDA Approved: MOXIFLOXACIN — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for moxifloxacin hydrochloride (MOXIFLOXACIN) from Fresenius Kabi USA, LLC, indicating a modificatio…
-
FDA approval · 2013-06-05FDA Approved: LEVOFLOXACIN — Original Application (Baxter Healthcare Corporation)
FDA approved Baxter Healthcare Corporation's Original Application for levofloxacin (generic), granting clearance for a generic version of th…
-
FDA approval · 2012-03-30FDA Approved: LEVOFLOXACIN — Original Application (Chartwell RX, LLC)
FDA approved an original ANDA for Levofloxacin, a generic antibiotic, submitted by Chartwell RX, LLC. The approval enables a generic version…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-03-27Clinical Trial Update: Comparative Study of 5 Days of M02-472 Clarithromycin Extended-Release Tablets to 7 Days of Clarithromycin Immediate-Release Tablets for the Treatment of Exacerbation of Chronic Bronchitis [Phase 3]
Phase 3 trial comparing five days of extended-release clarithromycin (M02-472) to seven days of immediate-release clarithromycin for acute b…
-
FDA approval · 2007-08-20FDA Approved: CLARITHROMYCIN — Original Application (Chartwell RX, LLC.)
FDA approved a generic version of clarithromycin from Chartwell RX, LLC through an Original Abbreviated New Drug Application (ANDA).